Core Laboratories Inc. (NYSE:CLB – Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $13.07, but opened at $13.76. Core Laboratories shares last traded at $13.53, with a volume of 20,938 shares changing hands.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on the company. Wall Street Zen upgraded Core Laboratories from a “sell” rating to a “hold” rating in a research report on Sunday. Weiss Ratings lowered shares of Core Laboratories from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 4th. Three research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $12.00.
View Our Latest Stock Report on CLB
Core Laboratories Stock Performance
Core Laboratories (NYSE:CLB – Get Free Report) last issued its earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.06. The business had revenue of $121.80 million for the quarter, compared to analyst estimates of $122.99 million. Core Laboratories had a net margin of 5.94% and a return on equity of 11.52%. Core Laboratories’s revenue was down 1.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.14 earnings per share. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. As a group, equities analysts expect that Core Laboratories Inc. will post 0.57 EPS for the current year.
Core Laboratories Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, June 1st. Stockholders of record on Monday, May 11th will be issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date is Monday, May 11th. Core Laboratories’s dividend payout ratio (DPR) is currently 6.15%.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the stock. Bank of America Corp DE raised its holdings in shares of Core Laboratories by 59.6% in the first quarter. Bank of America Corp DE now owns 224,618 shares of the oil and gas company’s stock valued at $3,771,000 after purchasing an additional 83,918 shares during the last quarter. Amundi increased its position in shares of Core Laboratories by 63.0% during the first quarter. Amundi now owns 31,857 shares of the oil and gas company’s stock valued at $535,000 after acquiring an additional 12,312 shares during the last quarter. State of Wyoming increased its position in shares of Core Laboratories by 267.7% during the first quarter. State of Wyoming now owns 4,626 shares of the oil and gas company’s stock valued at $78,000 after acquiring an additional 3,368 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Core Laboratories by 10.0% during the first quarter. Dimensional Fund Advisors LP now owns 1,352,329 shares of the oil and gas company’s stock valued at $22,705,000 after acquiring an additional 122,718 shares during the last quarter. Finally, Heartland Advisors Inc. purchased a new stake in shares of Core Laboratories during the first quarter valued at approximately $2,518,000. Institutional investors own 97.81% of the company’s stock.
Core Laboratories Company Profile
Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.
The company’s portfolio spans two primary service lines: reservoir description and production enhancement.
Featured Articles
- Five stocks we like better than Core Laboratories
- The Pentagon’s AI Pivot Supercharges Defense Stocks
- AAPL: Forget the iPhone—Services Will Drive the Next Phase of Growth
- Ackman and Berkshire Are Betting Against Each Other on AI
- The $132 Billion Infrastructure Pivot You Might Have Missed
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
